Dr. Goetz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1999 - 2003
- University of Michigan Health SystemResidency, Internal Medicine, 1996 - 1999
- University of Michigan Health SystemInternship, Internal Medicine, 1996 - 1997
- University of North Dakota School of Medicine and Health SciencesClass of 1996
Certifications & Licensure
- MN State Medical License 1999 - 2024
- MI State Medical License 1998 - 2002
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary Start of enrollment: 2004 Feb 01
- Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid Tumors Start of enrollment: 2003 Nov 01
- Irinotecan, Fluorouracil, Leucovorin, and Oxaliplatin as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2004 Mar 01
- Join now to see all
Publications & Presentations
PubMed
- Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer.Roberto A Leon-Ferre, Sarah Flora Jonas, Roberto Salgado, Sherene Loi, Vincent de Jong, Jodi M Carter, Torsten O Nielsen, Samuel Leung, Nazia Riaz, Stephen Chia, Gérôm...> ;JAMA. 2024 Apr 2
- Revisiting Combined Modality Therapy in Older Patients With Luminal Breast Cancer Through the Patient Lens.Cynthia Chauhan, Robert W Mutter, Matthew P Goetz, Jean L Wright> ;Journal of Clinical Oncology. 2024 Apr 2
- 2 citationsPatient-specific signaling signatures predict optimal therapeutic combinations for triple negative breast cancer.Alkhatib, H., Conage-Pough, J., Roy Chowdhury, S., Shian, D., Zaid, D., Rubinstein, A., Sonnenblick, A., Peretz-Yablonsky, T., Granit, A., Carmon, E., Kohale, I., Wang...> ;Molecular Cancer. 2024 Jan 16
- Join now to see all
Journal Articles
- ERβ-Mediated Induction of Cystatins Results in Suppression of TGFβ Signaling and Inhibition of Triple-Negative Breast Cancer MetastasisMatthew P Goetz, James N Ingle, Proceedings of the National Academy of Sciences
- Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast CancerMatthew P Goetz, Thomas J Saphner, Joseph A Sparano, Lynne I Wagner, Peter M Ravdin, Daniel F Hayes, Adam M Brufsky, Della F Makower, Sunil S Badve, Robert J Gray, Wil..., The New England Journal of Medicine
Press Mentions
- Atossa to Present a Trial in Progress Poster on Its Neoadjuvant Breast Cancer Phase 2 Clinical Trial, EVANGELINE, at the 2023 American Society of Clinical Oncology (ASCO) Annual MeetingMay 9th, 2023
- OS Advances Gather Steam in Breast CancerNovember 13th, 2022
- Mayo Clinic Scientists Awarded $12.1 Million NCI Grant for Breast Most Cancers AnalysisOctober 20th, 2022
- Join now to see all
Grant Support
- Tamoxifen Biotransformation Pathway PharmacogenomicsNational Cancer Institute2008–2011
Committees
- Member, Expert Panel, American Society of Clinical Oncology (ASCO) 2015 - Present
Professional Memberships
- Member
- Member
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: